Mantra Distributions Inc Pharmaceutical Import Profile — Canada (DGFT 2022–2026)

Name: Mantra Distributions Inc Pharmaceutical Import Records from India — 2 Products, $1.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Mantra Distributions Inc — Pharmaceutical Importer Profile (2026) | 2 Products, $1.1M Trade | TransData Nexus

Mantra Distributions Inc

Pharmaceutical Importer · Canada · Advanced Diabetes Medications Focus · $1.1M Total Trade · DGFT Verified

Mantra Distributions Inc is a pharmaceutical importer based in Canada with a total trade value of $1.1M across 2 products in 2 therapeutic categories. Based on 23 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Mantra Distributions Inc sources from 4 verified Indian suppliers, with Alembic Pharmaceuticals Limited accounting for 52.0% of imports.

Mantra Distributions Inc — Import Portfolio & Supplier Network

Mantra Distributions Inc import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Mantra Distributions Inc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Alembic Pharmaceuticals Limited	$833.2K	25	52.0%
Intas Pharmaceuticals Limited	$551.5K	24	34.4%
Msn Laboratories Private Limited

What Formulations Does Mantra Distributions Inc Import?

Formulation	Value	Ships
M-dapagliflozin 10MG 3x10t	$110.3K	3
M-dapagliflozin 10MG 100bt	$68.7K	2
Msn pharma m ticagrelor 90MG blister of 60 tabs	$63.4K	2
Pharma drugs and medi m-fluoxetine 20MG	$58.8K	2
M- dapagliflozin 10MG 3x10t	$50.0K	1
Ph.dru.& med.: pr m-pravastatin tablets20mg (Each tablet cont. pravastatin sodium PH.EUR. 20MG) [1x100t per	$50.0K	1
Ph.dru.& med.: pr m-pravastatin tablets40mg (Each tablet cont. pravastatin sodium PH.EUR. 40MG) [1x100t per	$50.0K	1
Ph.dru.& med.: pr m-pravastatin tablets10mg (Each tablet cont. pravastatin sodium PH.EUR. 10MG) [1x100t per	$50.0K	1
M-dapagliflozin 10MG tablets (dapagliflozin tablets 10MG) [29088 Pack x 3x10 tabs] b.no- 2405017039, 2405017040	$50.0K	1
M-dapagliflozin 10MG tablets (dapagliflozin tablets 10MG) [28776 Pack x 3x10 tabs] b.no- 2505001479, 2505001480	$50.0K	1
M-dapagliflozin 10MG tablets (dapagliflozin tablets 10MG) [8742 Pack x 100 tabs]b.no- 2505002948, 2505002900	$50.0K	1
Msn pharma m ticagrelor 90 MG 60 tabsmantra	$50.0K	1
M dapagliflozin 10MG tablets dapagliflozin tablets 10MG 28968 Pack x 3x10 tabs b no 2505006525 2505006526 md 05	$50.0K	1
M dapagliflozin 10MG tablets dapagliflozin tablets 10MG 8736 Pack x 100 tabs b no 2505008748 2505008747 md 05	$50.0K	1
M-dapagliflozin 5MG 3x10t	$46.0K	1

Mantra Distributions Inc imports 50 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Dapagliflozin	Advanced Diabetes Medications	$850.9K	19	1.7%	12
2	Pravastatin	Cardiovascular	$200.0K	4	0.6%	2

Mantra Distributions Inc imports 2 pharmaceutical products across 2 categories into Canada totaling $1.1M.

Mantra Distributions Inc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Mantra Distributions Inc is a Canadian pharmaceutical importer specializing in the acquisition of finished pharmaceutical formulations from international suppliers, particularly from India. The company is headquartered in Levis, Quebec, Canada, at 4865, rue de la Pascaline, G6W 0L9. As a pharmaceutical buyer, Mantra Distributions Inc plays a pivotal role in sourcing and importing pharmaceutical products to meet the demands of the Canadian market.

The company's import activities are primarily focused on finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, rather than raw active pharmaceutical ingredients (APIs) or bulk drugs. This strategic focus allows Mantra Distributions Inc to cater to the immediate needs of healthcare providers and patients by ensuring a steady supply of ready-to-use medications.

2Distribution Network

While specific details about Mantra Distributions Inc's warehouse locations and logistics capabilities are not publicly disclosed, the company is known to import pharmaceutical products from India, indicating established logistics channels between Canada and India. The company's geographic coverage within Canada is not explicitly detailed in the available data. However, as a pharmaceutical importer, it is reasonable to infer that Mantra Distributions Inc's distribution network is designed to supply various regions across Canada, ensuring that imported pharmaceutical products are accessible to healthcare providers and patients nationwide.

3Industry Role

Mantra Distributions Inc operates as a pharmaceutical importer in Canada's supply chain, focusing on sourcing finished pharmaceutical formulations from international suppliers, particularly from India. By importing ready-to-use medications, the company serves as a critical link between foreign manufacturers and the Canadian market, facilitating the availability of essential pharmaceutical products. This role is vital in ensuring that healthcare providers have access to a diverse range of medications to meet patient needs.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Mantra Distributions Inc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Mantra Distributions Inc's sourcing strategy exhibits a high degree of concentration, with the top five products accounting for 100% of the company's imports. The primary products imported include Dapagliflozin, a medication for advanced diabetes, and Pravastatin, a cardiovascular drug. This concentration suggests a strategic focus on specific therapeutic areas, likely driven by market demand and the company's expertise.

The company's reliance on a limited number of products may indicate a strategic choice to specialize in high-demand medications, potentially allowing for better negotiation terms with suppliers and streamlined operations. However, this approach also exposes Mantra Distributions Inc to risks associated with supply chain disruptions or regulatory changes affecting these specific products. Diversifying the product portfolio could mitigate such risks and enhance the company's resilience in the market.

2Supply Chain Resilience

Mantra Distributions Inc's supply chain resilience is influenced by its sourcing strategy, which is heavily concentrated on a few key products. The company's primary suppliers from India include Alembic Pharmaceuticals Limited, Intas Pharmaceuticals Limited, MSN Laboratories Private Limited, and Naari Pharma Private Limited. The substantial volume of imports from these suppliers indicates established and likely stable relationships.

Importing Pharmaceuticals into Canada — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Canada

1Regulatory Authority & Framework

In Canada, the importation and distribution of pharmaceutical products are regulated by Health Canada under the Food and Drugs Act and its associated regulations. This legislative framework ensures that all pharmaceutical products entering the Canadian market meet stringent safety, efficacy, and quality standards. (canada.ca)

Health Canada's regulatory oversight encompasses various aspects, including the approval of drug products, establishment licensing for importers, and compliance with Good Manufacturing Practices (GMP). These regulations are designed to protect public health by ensuring that imported pharmaceutical products are safe for use and meet the required standards.

2Import Licensing & GMP

To import pharmaceutical products into Canada, companies like Mantra Distributions Inc must obtain an Establishment Licence (EL) from Health Canada. This licence authorizes the company to import specific categories of drugs and ensures that the foreign manufacturing sites are listed on the importer's EL. (canada.ca)

Additionally, imported pharmaceutical products must comply with GMP standards. Health Canada requires evidence that foreign manufacturing sites adhere to GMP, which may include certifications such as EU GMP, WHO GMP, or PIC/S. This compliance is crucial for maintaining the safety and quality of pharmaceutical products available in Canada.

Mantra Distributions Inc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Mantra Distributions Inc's focus on importing advanced diabetes medications and cardiovascular drugs aligns with the significant demand for these therapeutic areas in Canada. The prevalence of diabetes and cardiovascular diseases in the Canadian population drives the need for effective treatments, making these product categories strategically important.

By concentrating on these high-demand areas, Mantra Distributions Inc can leverage its expertise and supplier relationships to ensure a consistent supply of essential medications, thereby meeting the needs of healthcare providers and patients across Canada.

2Sourcing Profile

Mantra Distributions Inc's sourcing strategy is centered on importing finished pharmaceutical formulations from India, focusing on generic drugs in the advanced diabetes and cardiovascular therapeutic areas. This approach allows the company to offer cost-effective alternatives to brand-name medications, making essential treatments more accessible to the Canadian market.

The company's preference for finished formulations over raw APIs or bulk drugs indicates a strategic decision to streamline operations and reduce the complexities associated with further processing or manufacturing. This sourcing profile enables Mantra Distributions Inc to efficiently meet the demand for ready-to-use medications in Canada.

Market Positioning

Seller's Guide — How to Become a Supplier to Mantra Distributions Inc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Mantra Distributions Inc, especially those offering high-quality generic formulations in the advanced diabetes and cardiovascular therapeutic areas. The company's established relationships with Indian suppliers and its focus on these specific product categories create a conducive environment for collaboration.

Potential gaps in Mantra Distributions Inc's current sourcing include a limited product portfolio and reliance on a few suppliers. New Indian suppliers can address these gaps by offering additional products or formulations that complement the existing portfolio, thereby enhancing the company's ability to meet diverse market demands.

2Requirements & Qualifications

Indian exporters seeking to supply Mantra Distributions Inc and the Canadian market must ensure that their products comply with Health Canada's regulatory requirements. This includes obtaining a Drug Identification Number (DIN) for each product, ensuring that the foreign manufacturing site adheres to Good Manufacturing Practices (GMP), and obtaining an Establishment Licence (EL) for the activity of import. (canada.ca)

Additionally, labeling must be in both English and French, and include all necessary information such as dosage instructions, ingredients, and any applicable warnings.

Frequently Asked Questions — Mantra Distributions Inc

What products does Mantra Distributions Inc import from India?

Mantra Distributions Inc imports 2 pharmaceutical products across 2 categories. Top imports: Dapagliflozin ($850.9K), Pravastatin ($200.0K).

Who supplies pharmaceuticals to Mantra Distributions Inc from India?

Mantra Distributions Inc sources from 4 verified Indian suppliers. The primary supplier is Alembic Pharmaceuticals Limited (52.0% of imports, $833.2K).

What is Mantra Distributions Inc's total pharmaceutical import value?

Mantra Distributions Inc's total pharmaceutical import value from India is $1.1M, based on 23 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Mantra Distributions Inc focus on?

Mantra Distributions Inc imports across 2 categories. The largest: Advanced Diabetes Medications (81.0%), Cardiovascular (19.0%).

Get Full Mantra Distributions Inc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.